New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance-Reference-Cited by-同舟云学术

New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance

Published:2023-07-12 Issue:7 Volume:9 Page:1297-1312
ISSN:2374-7943
Container-title:ACS Central Science
language:en
Short-container-title:ACS Cent. Sci.

Author:

Kalathil Akil A.¹,Guin Subham¹,Ashokan Akash¹²,Basu Uttara¹²,Surnar Bapurao¹²,Delma Katiana S.³,Lima Leonor M.³,Kryvenko Oleksandr N.²³⁴⁵,Dhar Shanta¹²⁶^ORCID

Affiliation:

1. NanoTherapeutics Research Laboratory, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida 33136, United States

2. Sylvester Comprehensive Cancer Centre, Miller School of Medicine, University of Miami, Miami, Florida 33136, United States

3. Department of Pathology and Laboratory Medicine, Miller School of Medicine, University of Miami, Miami, Florida 33136, United States

4. Department of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, Florida 33136, United States

5. Desai Sethi Urology Institute, Miller School of Medicine, University of Miami, Miami, Florida 33136, United States

6. Department of Chemistry, University of Miami, Coral Gables, Florida 33146, United States

Funder

National Cancer Institute

Florida Department of Health

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acscentsci.3c00286

Reference68 articles.

1. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)

2. Otto Warburg's contributions to current concepts of cancer metabolism

3. Tumor Cell Metabolism: Cancer's Achilles' Heel

4. Cancer Statistics, 2010

5. Prostate cancer

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SPINK5-FTH1 axis to overcome cisplatin resistance in head and neck carcinoma cells;2024-08-19

2. Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy;ACS Pharmacology & Translational Science;2024-08-12

3. Localizedin vivoprodrug activation using radionuclides;2024-08-06

4. Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites;Proceedings of the National Academy of Sciences;2024-05-06

5. Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm;Heliyon;2024-04